|
|
Natriuretic Peptides in the Gastrointestinal System
Sponsored by
APS
Gastrointestinal and Liver Physiology Section
Ion Channels and Transporters Tracks
Wednesday, April 22 — 10:30 AM-12:30 PM
Ernest N. Morial Convention Center, Room 235/236
|
| Chaired: |
William R. Gower, Univ. of South Florida
John R. Dietz, Univ. of South Florida |
The natriuretic peptides, which include atrial natriuretic peptide (ANP),
B-type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP),
act as important modulators of blood volume and blood pressure and in
addition can act as paracrine regulators of cellular function. Recent
evidence suggests a significant role for these peptides in
gastrointestinal physiology. ANP mRNA is expressed in both the stomach
and intestine with substantial expression in the antrum of the stomach
and ANP has been shown to be secreted from the stomach in response to
cholinergic stimuli. ANP appears to be synthesized by enterochromaffin
cells in rat gastric mucosa, particularly in the fundus of the stomach.
Thus, ANP may act not only as a regional autocrine and paracrine
regulator, but also as an endocrine regulatory peptide. Both the A-type
and C-type natriuretic peptide receptors are present in the stomach and
intestine and ANP, BNP and CNP have been shown to decrease gastric
motility. Also, BNP decreases gastric emptying and gastrointestinal
absorption. ANP appears to have a dual role in modulating acid secretion
by the stomach. Centrally applied CNP enhances pancreatic secretion
through a vagal pathway which suggests that the CNP response is mediated
by the activation of natriuretic peptide guanylyl cyclase coupled
receptors in the brain. Furthermore, CNP interacts with cholecystokinin
and secretin in the brain to modify pancreatic secretion. This symposium
will review the growing body of evidence supporting a role for
natriuretic peptides in the regulation of gastrointestinal function.
|
10:30 AM |
Natriuretic peptides in the gastrointestinal
system: an overview.
William R. Gower, Univ. of South Florida |
|
11:15 AM |
Pathophysiological levels of B-type natriuretic
peptide inhibit gastric function.
John R. Dietz, Univ. of South Florida |
|
11: 40 AM |
C-Type natriuretic peptide receptor and G
proteins in the regulation of gastrointestinal smooth muscle.
K.S. Murthy, Virginia Commonwealth Univ. |
|
12:05 PM |
Role of natriuretic peptides in exocrine
secretion of the pancreas.
Liliana G. Bianciotti, Univ.of Buenos Aires |
|
|
|
|
|
|
|
|
|
|
|
|
|
|